NEW YORK (GenomeWeb) – Celgene has given the Myeloma Institute at the University of Arkansas for Medical Sciences $10 million to create the Bart Barlogie Center for Molecular Diagnostics and the Celgene Distinguished Endowed Chair for Molecular Therapeutics, the university announced on Monday.

Since the myeloma program at UAMS was founded in 1989, the school has seen more than 11,000 patients and performed more than 9,000 peripheral blood stem cell transplants, UAMS said. It further noted that since 2001, the number of myeloma survivors has increased by 57 percent. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.